Die atypische Depression

• Literatur

• 1 Harald B, Gordon P. Meta-review of depressive subtyping models. J Affect Disord 2012; 139: 126-140
• 2 Kendler KS, Eaves LJ, Walters EE et al. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 1996; 53: 391-399
• 3 West ED, Dally PJ. Effects of iproniazid in depressive syndromes. Br Med J 1959; 1: 1491-1494
• 4 Klein DF, Davis JM. Diagnosis and drug treatment of psychiatric disorders. Baltimore: Williams & Wilkins; 1969
• 5 Seemuller F, Riedel M, Wickelmaier F et al. Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity. J Affect Disord 2008; 108: 271-278
• 6 Parker G, Roy K, Mitchell P et al. Atypical depression: a reappraisal. Am J Psychiatry 2002; 159: 1470-1479
• 7 Thase ME. Introduction: new directions in the treatment of atypical depression. J Clin Psychiatry 2007; 68 (Suppl. 03) 4-9
• 8 Angst J, Gamma A, Benazzi F et al. Melancholia and atypical depression in the Zurich study: epidemiology, clinical characteristics, course, comorbidity and personality. Acta Psychiatr Scand Suppl 2007; 72-84
• 9 Gremaud-Heitz DJ, Stewart JW, Dammann G. Konzept der atypischen Depression und deutsche Übersetzung der „Atypical Depression Diagnostic Scale ADDS“. Schweizer Archiv für Neurology und Psychiatrie 2011; 162: 148-154
• 10 Agosti V, Stewart JW. Atypical and non-atypical subtypes of depression: comparison of social functioning, symptoms, course of illness, co-morbidity and demographic features. J Affect Disord 2001; 65: 75-79
• 11 Detre T, Himmelhoch J, Swartzburg M et al. Hypersomnia and manic-depressive disease. Am J Psychiatry 1972; 128: 1303-1305
• 12 Blanco C, Vesga-Lopez O, Stewart JW et al. Epidemiology of major depression with atypical features: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry 2012; 73: 224-232
• 13 Matza LS, Revicki DA, Davidson JR et al. Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. Arch Gen Psychiatry 2003; 60: 817-826
• 14 O’Keane V, Frodl T, Dinan TG. A review of atypical depression in relation to the course of depression and changes in HPA axis organization. Psychoneuroendocrinology 2012; 37: 1589-1599
• 15 Lasserre AM, Glaus J, Vandeleur CL et al. Depression with atypical features and increase in obesity, Body Mass Index, waist circumference, and fat mass: a prospective, population-based study. J Am Med Assoc Psychiatry 2014; 71: 880
• 16 Stewart JW, McGrath PJ, Quitkin FM et al. DSM-IV depression with atypical features: is it valid?. Neuropsychopharmacology 2009; 34: 2625-2632
• 17 Thase ME. Atypical depression: useful concept, but it’s time to revise the DSM-IV criteria. Neuropsychopharmacology 2009; 34: 2633-2641
• 18 Henkel V, Mergl R, Allgaier AK et al. Treatment of depression with atypical features: a meta-analytic approach. Psychiatry Res 2006; 141: 89-101
• 19 Quitkin FM, McGrath PJ, Stewart JW et al. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression. Arch Gen Psychiatry 1989; 46: 787-793
• 20 McGrath PJ, Stewart JW, Janal MN et al. A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. Am J Psychiatry 2000; 157: 344-350
• 21 Quitkin FM, McGrath PJ, Stewart JW et al. Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication. Arch Gen Psychiatry 1990; 47: 935-941
• 22 Stewart JW, McGrath PJ, Fava M et al. Do atypical features affect outcome in depressed outpatients treated with citalopram?. Int J Neuropsychopharmacol 2010; 13: 15-30
• 23 Sogaard J, Lane R, Latimer P et al. A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression. J Psychopharmacol 1999; 13: 406-414
• 24 Goodnick PJ, Dominguez RA, DeVane CL et al. Bupropion slow-release response in depression: diagnosis and biochemistry. Biol Psychiatry 1998; 44: 629-632
• 25 McGrath PJ, Stewart JW, Quitkin FM et al. Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement. J Clin Psychopharmacol 1994; 14: 347-352
• 26 Husain MM, McClintock SM, Rush AJ et al. The efficacy of acute electroconvulsive therapy in atypical depression. J Clin Psychiatry 2008; 69: 406-411
• 27 Jarrett RB, Schaffer M, McIntire D et al. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999; 56: 431-437
• 28 Stewart JW, Garfinkel R, Nunes EV et al. Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Clin Psychopharmacol 1998; 18: 429-434
• 29 Weinstock LM, Munroe MK, Miller IW. Behavioral activation for the treatment of atypical depression: a pilot open trial. Behav Modif 2011; 35: 403-424